Xenon Pharmaceuticals Cash from Investing (TTM) Analysis

Xenon Pharmaceuticals Inc (XENE)

42.99 +0.50 (+1.18%) USD | NASDAQ | May 02, 16:00

43.02 +0.03 (+0.07%) Pre-Market: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2014. Upgrade now.

Date	Value
December 31, 2023	-117.17M
September 30, 2023	108.22M
June 30, 2023	-173.91M
March 31, 2023	-200.49M
December 31, 2022	-296.00M
September 30, 2022	-497.10M
June 30, 2022	-247.43M
March 31, 2022	-240.55M
December 31, 2021	-246.77M
September 30, 2021	11.86M
June 30, 2021	-21.74M
March 31, 2021	-19.00M
December 31, 2020	-16.82M
September 30, 2020	-120.34M
June 30, 2020	-94.57M
March 31, 2020	-112.13M
December 31, 2019	-66.21M
September 30, 2019	-18.45M
June 30, 2019	-49.54M

Date	Value
March 31, 2019	-40.97M
December 31, 2018	-28.99M
September 30, 2018	-10.63M
June 30, 2018	12.63M
March 31, 2018	20.02M
December 31, 2017	24.29M
September 30, 2017	-13.74M
June 30, 2017	-13.76M
March 31, 2017	-38.51M
December 31, 2016	-47.84M
September 30, 2016	-15.76M
June 30, 2016	-6.939M
March 31, 2016	8.62M
December 31, 2015	10.19M
September 30, 2015	11.38M
June 30, 2015	-2.741M
March 31, 2015	-1.415M
December 31, 2014	-3.244M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-497.10M

Minimum

Sep 2022

108.22M

Maximum

Sep 2023

-127.27M

Average

-112.13M

Median

Mar 2020

Cash from Investing (TTM) Benchmarks